tradingkey.logo


Zimmer Biomet Holdings Inc

ZBH

90.620USD

-1.030-1.12%
āļ›āļīāļ” 08/01, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
17.93BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
19.63P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Zimmer Biomet Holdings Inc āļšāļĢāļīāļĐāļąāļ—
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ZBH
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Zimmer Biomet Holdings Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļJul 25, 2001
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­2001
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Ivan Tornos
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™17000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Jul 25
āļ—āļĩāđˆāļ­āļĒāļđāđˆ345 E Main St
āđ€āļĄāļ·āļ­āļ‡WARSAW
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNYSE Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ46580-2746
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ15742676131
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.zimmerbiomet.com/en
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ZBH
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļJul 25, 2001
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­2001
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
19.62K
-8.40%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
2.54K
+20.36%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
19.62K
-8.40%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Knees
792.90M
41.53%
Hips
495.80M
25.97%
S E T
470.50M
24.65%
Other product category
149.90M
7.85%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
1.11B
58.33%
International
795.50M
41.67%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Knees
792.90M
41.53%
Hips
495.80M
25.97%
S E T
470.50M
24.65%
Other product category
149.90M
7.85%
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 1 āļŠ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 1 āļŠ.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
11.61%
Dodge & Cox
10.15%
T. Rowe Price Associates, Inc.
7.16%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Global Advisors (US)
4.42%
Other
61.03%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
11.61%
Dodge & Cox
10.15%
T. Rowe Price Associates, Inc.
7.16%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Global Advisors (US)
4.42%
Other
61.03%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
49.71%
Investment Advisor/Hedge Fund
34.23%
Hedge Fund
4.36%
Pension Fund
1.97%
Research Firm
1.88%
Bank and Trust
1.33%
Sovereign Wealth Fund
1.10%
Individual Investor
0.13%
Insurance Company
0.08%
Other
5.22%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
1988
194.30M
98.21%
-1.70M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
2023Q1
1993
190.05M
90.59%
-15.03M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
22.96M
11.61%
+168.35K
+0.74%
Mar 31, 2025
Dodge & Cox
20.09M
10.15%
+522.66K
+2.67%
Apr 30, 2025
T. Rowe Price Associates, Inc.
14.16M
7.16%
-188.21K
-1.31%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
11.13M
5.63%
+183.28K
+1.67%
Mar 31, 2025
State Street Global Advisors (US)
8.75M
4.42%
-229.25K
-2.55%
Mar 31, 2025
American Century Investment Management, Inc.
5.25M
2.65%
-670.93K
-11.33%
Mar 31, 2025
Geode Capital Management, L.L.C.
5.06M
2.56%
+178.23K
+3.65%
Mar 31, 2025
PRIMECAP Management Company
4.68M
2.37%
-114.18K
-2.38%
Mar 31, 2025
Columbia Threadneedle Investments (US)
4.47M
2.26%
+3.12M
+230.65%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: 2 āļŠāļąāđˆāļ§āđ‚āļĄāļ‡āļ—āļĩāđˆāđāļĨāđ‰āļ§
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: 2 āļŠāļąāđˆāļ§āđ‚āļĄāļ‡āļ—āļĩāđˆāđāļĨāđ‰āļ§
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
VanEck Morningstar Wide Moat Value ETF
4.09%
Langar Global HealthTech ETF
2.94%
Leatherback Long/Short Alternative Yield ETF
2.82%
VanEck Morningstar ESG Moat ETF
2.41%
American Century Focused Large Cap Value ETF
2.31%
VanEck Morningstar Wide Moat ETF
2.22%
iShares U.S. Medical Devices ETF
2.05%
Invesco Bloomberg Pricing Power ETF
1.91%
SPDR S&P Health Care Equipment ETF
1.77%
First Trust Indxx Medical Devices ETF
1.62%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™4.09%
Langar Global HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.94%
Leatherback Long/Short Alternative Yield ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.82%
VanEck Morningstar ESG Moat ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.41%
American Century Focused Large Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.31%
VanEck Morningstar Wide Moat ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.22%
iShares U.S. Medical Devices ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.05%
Invesco Bloomberg Pricing Power ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.91%
SPDR S&P Health Care Equipment ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.77%
First Trust Indxx Medical Devices ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.62%
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 996.70M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Aug 25, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2023 going ex on Sep 28, 2023 with reinvestment option
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 15, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2023 going ex on Jun 23, 2023 with reinvestment option
Jun 26, 2023
Jul 31, 2023
Jun 23, 2023
Mar 08, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 28, 2023 going ex on Mar 28, 2023
Mar 29, 2023
Apr 28, 2023
Mar 28, 2023
Dec 15, 2022
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 31, 2023
Dec 23, 2022
Aug 26, 2022
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™